Cardinal to buy private generic drug distributor for US$1.12 billion
Published Fri, Jun 5, 2015 · 11:26 AM
[BENGALURU] Cardinal Health Inc said it would buy privately held drug distributor Harvard Drug Group for US$1.12 billion.
Cardinal said it expects the deal to add more than 15 US cents per share to adjusted earnings from continuing operations in 2016 and 17 US cents per share in 2017.
REUTERS
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years
Sheng Siong Q1 net profit up 9.3% on higher revenue
Nestle sales growth sputters on US slump, vitamin snags
Hermes Q1 sales jump 17% on strong China demand
Cordlife’s independent auditor to retire after issuing disclaimer of opinion on FY2023 financials
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO